SEC Form 4 · accession 0001104659-18-004313
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renee Selman
Officer — Chief Commercial Officer
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 25, 2018 | M | 17,500 | — | A | 78,083 | D | |
| Common Stock | Jan 25, 2018 | F | 6,455 | $3.32 | D | 71,628 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F2 | $3.46 | Jan 24, 2018 | A | 107,000 | A | — | Jan 23, 2028 | Common Stock | 107,000 | 107,000 | D |
| Restricted Stock UnitsF1,F3 | — | Jan 24, 2018 | A | 13,200 | A | — | — | Common Stock | 13,200 | 48,200 | D |
| Restricted Stock UnitsF1,F4 | — | Jan 25, 2018 | M | 17,500 | A | — | — | Common Stock | 17,500 | 30,700 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2This option was granted on January 24, 2018. 25% of the shares subject to the stock option vest on January 24, 2019, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 24, 2022.
- F3The restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019.
- F4The restricted stock units were granted on January 25, 2017 and vest as follows: 17,500 units vested and were delivered on January 25, 2018, and 17,500 units will vest and be delivered on January 25, 2019.